Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune responses to IXIARO in elderly vs younger adults
2010-020450-33Phase 4Completed
- Sponsor
- Institute of Specific Prophylaxis and Tropical Medicine
- Start
- May 2010
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of Japanese encephalitis inactivated vaccine in Japanese encephalitis (JE) (2 arms), sponsored by Institute of Specific Prophylaxis and Tropical Medicine. Primary endpoint: Antibody titres at 10 weeks after first vaccination. Started May 2010; status: completed.
02
Drugs
Japanese encephalitis inactivated vaccine
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on 2010-020450-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020450-33.